Viral genes as oncolytic agents for cancer therapy

Cellular and Molecular Life Sciences

Volumn 72, Issue 6, 2015, Pages 1073-1094

  Gupta, Shishir Kumar ^a   Gandham, Ravi Kumar ^a   Sahoo, A P ^a   Tiwari, A K ^a  

^a INDIAN VETERINARY RESEARCH INSTITUTE   (India)

Author keywords

Adenovirus; Anticancer genes; Apoptin; Apoptosis; B19PV; Cancer; Chicken infectious anemia; CPV; E4orf4; Gene therapy; H 1PV; MVM; NS1; Parvovirus; VP3

Indexed keywords

ADENOVIRUS E4 OPEN READING FRAME 4 PROTEIN; APOPTIN; NONSTRUCTURAL PROTEIN 1; UNCLASSIFIED DRUG; VIRUS PROTEIN; VIRUS VECTOR; CAPSID PROTEIN; ONCOLYTIC VIRUS; VP3 PROTEIN, CHICKEN ANEMIA VIRUS;

ADENOVIRIDAE; ADENOVIRUS E4; AMINO ACID SEQUENCE; ANTINEOPLASTIC ACTIVITY; ANTIPROLIFERATIVE ACTIVITY; APOPTOSIS; CANCER INHIBITION; CANCER THERAPY; CELL NUCLEUS; CYTOPLASM; EPSTEIN BARR VIRUS; FELINE PANLEUKOPENIA VIRUS; GYROVIRUS; H-1 PARVOVIRUS; HUMAN; HUMAN PARVOVIRUS B19; MINUTE VIRUS OF MICE; NONHUMAN; NONVIRAL GENE DELIVERY SYSTEM; NS1 GENE; ONCOLYTIC VIROTHERAPY; PROTEIN FUNCTION; PROTEIN LOCALIZATION; PROTEIN PHOSPHORYLATION; PROTEIN STRUCTURE; PROTEIN SYNTHESIS; REVIEW; SIGNAL TRANSDUCTION; TUMOR IMMUNITY; VIRAL GENE DELIVERY SYSTEM; VIRAL GENE THERAPY; VIRUS GENE; ANIMAL; GENETICS; NEOPLASMS; PARVOVIRIDAE; PROCEDURES;

ADENOVIRIDAE; ANIMALS; APOPTOSIS; CAPSID PROTEINS; CHICKEN ANEMIA VIRUS; GENES, VIRAL; HUMANS; NEOPLASMS; ONCOLYTIC VIROTHERAPY; ONCOLYTIC VIRUSES; PARVOVIRUS;

EID: 84925511698     PISSN: 1420682X     EISSN: 14209071     Source Type: Journal    
DOI: 10.1007/s00018-014-1782-1     Document Type: Review

References (212)

1. Hollstein M, Sidransky D, Vogelstein B, Harris CC (1991) p53 mutations in human cancers. Science 253(5015):49-53
2. Grimm S, Noteborn M (2010) Anticancer genes: inducers of tumour-specific cell death signalling. Trends Mol Med 16(2):88-96
3. Everett H, McFadden G (1999) Apoptosis: an innate immune response to virus infection. Trends Mirobiol 7(4):160-165
4. Teodoro JG, Branton PE (1997) Regulation of apoptosis by viral gene products. J Virol 71(3):1739
5. O'Brien V (1998) Viruses and apoptosis. J Gen Virol 79(8):1833-1845
6. Henderson S, Huen D, Rowe M, Dawson C, Johnson G, Rickinson A (1993) Epstein-Barr virus-coded BHRF1 protein, a viral homologue of Bcl-2, protects human B cells from programmed cell death. Proc Natl Acad Sci 90(18):8479-8483
7. Han J, Sabbatini P, Perez D, Rao L, Modha D, White E (1996) The E1B 19K protein blocks apoptosis by interacting with and inhibiting the p53-inducible and death-promoting Bax protein. Genes Dev 10(4):461-477
8. Cuconati A, White E (2002) Viral homologs of BCL-2: role of apoptosis in the regulation of virus infection. Genes Dev 16(19):2465-2478
9. Kepp O, Senovilla L, Galluzzi L, Panaretakis T, Tesniere A, Schlemmer F, Madeo F, Zitvogel L, Kroemer G (2009) Viral subversion of immunogenic cell death. Cell Cycle 8(6):860-869
10. Lechner MS, Laimins LA (1994) Inhibition of p53 DNA binding by human papillomavirus E6 proteins. J Virol 68(7):4262-4273
11. King KL, Cidlowski JA (1998) Cell cycle regulation and apoptosis 1. Annu Rev Physiol 60(1):601-617
12. Roulston A, Marcellus RC, Branton PE (1999) Viruses and apoptosis. Annu Rev Microbiol 53(1):577-628
13. Marcellus RC, Teodoro JG, Wu T, Brough DE, Ketner G, Shore GC, Branton PE (1996) Adenovirus type 5 early region 4 is responsible for E1A-induced p53-independent apoptosis. J Virol 70(9):6207-6215
14. Webster K, Taylor A, Gaston K (2001) Oestrogen and progesterone increase the levels of apoptosis induced by the human papillomavirus type 16 E2 and E7 proteins. J Gen Virol 82(1):201-213
15. Noteborn MH (2004) Chicken anemia virus induced apoptosis: underlying molecular mechanisms. Vet Mirobiol 98(2):89-94
16. Perry SW, Norman JP, Litzburg A, Zhang D, Dewhurst S, Gelbard HA (2005) HIV-1 transactivator of transcription protein induces mitochondrial hyperpolarization and synaptic stress leading to apoptosis. J Immunol 174(7):4333-4344
17. Hristov G, Kramer M, Li J, El-Andaloussi N, Mora R, Daeffler L, Zentgraf H, Rommelaere J, Marchini A (2010) Through its nonstructural protein NS1, parvovirus H-1 induces apoptosis via accumulation of reactive oxygen species. J Virol 84(12):5909-5922
18. Ravindra PV, Tiwari AK, Sharma B, Rajawat YS, Ratta B, Palia S, Sundaresan NR, Chaturvedi U, Aruna Kumar GB, Chindera K, Saxena M, Subudhi PK, Rai A, Chauhan RS (2008) HN protein of Newcastle disease virus causes apoptosis in chicken embryo fibroblast cells. Arch Virol 153(4):749-754
19. Decaro N, Buonavoglia C (2012) Canine parvovirus-a review of epidemiological and diagnostic aspects, with emphasis on type 2c. Vet Microbiol 155(1):1-12
20. Doley J, Singh LV, Kumar GR, Sahoo AP, Saxena L, Chaturvedi U, Saxena S, Kumar R, Singh PK, Rajmani RS, Santra L, Palia SK, Tiwari S, Harish DR, Kumar A, Desai GS, Gupta S, Gupta SK, Tiwari AK (2014) Canine parvovirus type 2a (CPV-2a)-induced apoptosis in MDCK involves both extrinsic and intrinsic pathways. Appl Biochem Biotechnol 172(1):497-508
21. Rommelaere J, Geletneky K, Angelova AL, Daeffler L, Dinsart C, Kiprianova I, Schlehofera JR, Raykova Z (2010) Oncolytic parvoviruses as cancer therapeutics. Cytokine Growth Factor Rev 21(2):185-195
22. Geletneky K, Huesing J, Rommelaere J, Schlehofer JR, Leuchs B, Dahm M, Krebs O, Doeberitz MVK, Huber B, Hajda J (2012) Phase I/IIa study of intratumoral/intracerebral or intravenous/intracerebral administration of Parvovirus H-1 (ParvOryx) in patients with progressive primary or recurrent glioblastoma multiforme: ParvOryx01 protocol. BMC Cancer 12(1):99
23. Bauder B, Suchy A, Gabler C, Weissenböck H (2000) Apoptosis in feline panleukopenia and canine parvovirus enteritis. J Vet Med 47(10):775-784
24. Bar S, Rommelaere J, Nuesch JP (2013) Vesicular transport of progeny parvovirus particles through ER and Golgi regulates maturation and cytolysis. PLoS Pathog 9:e1003605
25. Nuesch JP, Rommelaere J (2006) NS1 interaction with CKII alpha: novel protein complex mediating parvovirus-induced cytotoxicity. J Virol 80:4729-4739
26. Di Piazza M, Mader C, Geletneky K, Herrero Y, Calle M, Weber E, Schlehofer J, Deleu L, Rommelaere J (2007) Cytosolic activation of cathepsins mediates parvovirus H-1-induced killing of cisplatin and TRAIL-resistant glioma cells. J Virol 81:4186-4198
27. Cotmore SF, Tattersall P (2007) Parvoviral host range and cell entry mechanisms. Adv Virus Res 70:183-232
28. Krady JK, Ward DC (2007) Transcriptional activation by the parvoviral nonstructural protein NS-1 is mediated via a direct interaction with Sp1. Mol Cell Biol 15:524-533
29. Lorson C, Pearson J, Burger L, Pintel DJ (1998) An Sp1-binding site and TATA element are sufficient to support full transactivation by proximally bound NS1 protein of minute virus of mice. Virology 240:326-337
30. Marks F, Gschwendt M (1996) Protein kinase C. In: Protein phosphorylation, pp 81-116
31. Caillet-Fauquet P, Perros M, Brandenburger A, Spegelaere P, Rommelaere J (1990) Programmed killing of human cells by means of an inducible clone of parvoviral genes encoding non-structural proteins. EMBO J 9:2989-2995
32. Mousset S, Ouadrhiri Y, Caillet-Fauquet P, Rommelaere J (1994) The cytotoxicity of the autonomous parvovirus minute virus of mice nonstructural proteins in FR3T3 rat cells depends on oncogene expression. J Virol 68:6446-6453
33. Op De Beeck A, Anouja F, Mousset S, Rommelaere J, Caillet-Fauquet P (1995) The nonstructural proteins of the autonomous parvovirus minute virus of mice interfere with the cell cycle, inducing accumulation in G2. Cell Growth Differ 6:781-787
34. Bashir T, Rommelaere J, Cziepluch C (2001) In vivo accumulation of cyclin A and cellular replication factors in autonomous parvovirus minute virus of mice-associated replication bodies. J Virol 75(9):4394-4398
35. Ruiz Z, Mihaylov IS, Cotmore SF, Tattersall P (2011) Recruitment of DNA replication and damage response proteins to viral replication centers during infection with NS2 mutants of minute virus of mice (MVM). Virology 410(2):375-384
36. Anouja F, Wattiez R, Mousset S, Caillet-Fauquet P (1997) The cytotoxicity of the parvovirus minute virus of mice nonstructural protein NS1 is related to changes in the synthesis and phosphorylation of cell proteins. J Virol 71(6):4671-4678
37. Corbau R, Duverger V, Rommelaere J, Nüesch JP (2000) Regulation of MVM NS1 by protein kinase C: impact of mutagenesis at consensus phosphorylation sites on replicative functions and cytopathic effects. Virology 278(1):151-167
38. Nüesch JP, Christensen J, Rommelaere J (2001) Initiation of minute virus of mice DNA replication is regulated at the level of origin unwinding by atypical protein kinase C phosphorylation of NS1. J Virol 75(13):5730-5739
39. Lachmann S, Rommeleare J, Nüesch JP (2003) Novel PKCη is required to activate replicative functions of the major nonstructural protein NS1 of minute virus of mice. J Virol 77(14):8048-8060
40. Nüesch JP, Rommelaere J (2007) A viral adaptor protein modulating casein kinase II activity induces cytopathic effects in permissive cells. Proc Natl Acad Sci 104(30):12482-12487
41. Nüesch JP, Lachmann S, Corbau R, Rommelaere J (2003) Regulation of minute virus of mice NS1 replicative functions by atypical PKCλ in vivo. J Virol 77(1):433-442
42. Lachmann S, Bär S, Rommelaere J, Nüesch JP (2008) Parvovirus interference with intracellular signalling: mechanism of PKCη activation in MVM-infected A9 fibroblasts. Cell Mirobiol 10(3):755-769
43. Nüesch JP, Bär S, Lachmann S, Rommelaere J (2009) Ezrin-radixin-moesin family proteins are involved in parvovirus replication and spreading. J Virol 83(11):5854-5863
44. De Beeck AO, Sobczak-Thepot J, Sirma H, Bourgain F, Brechot C, Caillet-Fauquet P (2001) NS1-and minute virus of mice-induced cell cycle arrest: involvement of p53 and p21 cip1. J Virol 75(22):11071-11078
45. Ohshima T, Yoshida E, Nakajima T, Yagami KI, Fukamizu A (2001) Effects of interaction between parvovirus minute virus of mice NS1 and coactivator CBP on NS1-and p53-transactivation. Int J Mol Med 7(1):49-103
46. Mincberg M, Gopas J, Tal J (2011) Minute virus of mice (MVMp) infection and NS1 expression induce p53 independent apoptosis in transformed rat fibroblast cells. Virology 412(1):233-243
47. Adeyemi RO, Pintel DJ (2012) Replication of minute virus of mice in murine cells is facilitated by virally induced depletion of p21. J Virol 86(15):8328-8332
48. Christensen J, Tattersall P (2002) Parvovirus initiator protein NS1 and RPA coordinate replication fork progression in a reconstituted DNA replication system. J Virol 76(13):6518-6531
49. Nüesch JP, Lachmann S, Rommelaere J (2005) Selective alterations of the host cell architecture upon infection with parvovirus minute virus of mice. Virology 331(1):159-174
50. Bär S, Daeffler L, Rommelaere J, Nüesch JP (2008) Vesicular egress of non-enveloped lytic parvoviruses depends on gelsolin functioning. PLoS Pathog 4(8):e1000126
51. Bhattacharya B et al (1990) Tropomyosins of human mammary epithelial cells: consistent defects of expression in mammary carcinoma cell lines. Cancer Res 50(7):2105-2112
52. Wizla P, Begue A, Loison I, Richard A, Caillet-Fauquet P, Stéhelin D (2010) Ectopic expression of H-1 parvovirus NS1 protein induces alterations in actin filaments and cell death in human normal MRC-5 and transformed MRC-5 SV2 cells. Arch Virol 155(5):771-775
53. Rayet B, Lopez-Guerrero JA, Rommelaere J, Dinsart C (1998) Induction of programmed cell death by parvovirus H-1 in U937 cells: connection with the tumor necrosis factor alpha signalling pathway. J Virol 72:8893-8903
54. Ohshima T, Iwama M, Ueno Y, Sugiyama F, Nakajima T, Fukamizu A, Yagami KI (1998) Induction of apoptosis in vitro and in vivo by H-1 parvovirus infection. J Gen Virol 79(12):3067-3071
55. Ran ZH, Rayet B, Rommelaere J, Faisst S (1999) Parvovirus H-1-induced cell death: influence of intracellular NAD consumption on the regulation of necrosis and apoptosis. Virus Res 65(2):161-174
56. Moehler M, Blechacz B, Weiskopf N, Zeidler M, Stremmel W, Rommelaere J et al (2001) Effective infection, apoptotic cell killing and gene transfer of human hepatoma cells but not primary hepatocytes by parvovirus H1 and derived vectors. Cancer Gene Ther 8:158-167
57. Zhao D, Cai C, Wang Y, Xiao S, Zheng Q (2014) Specific anti-gastric cancer effects of a recombinant plasmid expressing nonstructural protein 1 of parvovirus H1. Sau Med J 35(4):336-345
58. Wang YY, Liu J, Zheng Q, Ran ZH, Salome N, Vogel M, Rommelaere J, Xiao SD, Wang Z (2012) Effect of the parvovirus H-1 non-structural protein NS1 on the tumorigenicity of human gastric cancer cells. J Dig Dis 13(7):366-373
59. Nüesch JP, Lacroix J, Marchini A, Rommelaere J (2012) Molecular pathways: rodent parvoviruses-mechanisms of oncolysis and prospects for clinical cancer treatment. Clin Cancer Res 18(13):3516-3523
60. Nüesch JP, Rommelaere J (2014) Tumor suppressing properties of rodent parvovirus NS1 proteins and their derivatives. In: Anticancer genes. Springer, London, pp 99-124
61. Brown KE, Young NS, Liu JM (1994) Molecular, cellular and clinical aspects of parvovirus B19 infection. Crit Rev Oncol/Haematol 16(1):1-31
62. Young NS, Brown KE (2004) Parvovirus B19. N Engl J Med 350(6):586-597
63. Alvarez-Lafuente R, Fernandez-Gutierrez B, Jover JA, Judez E, Loza E, Clemente D, Garcia-asenjo JA, Lamas JR (2005) Human parvovirus B19, varicella zoster virus, and human herpes virus 6 in temporal artery biopsy specimens of patients with giant cell arteritis: analysis with quantitative real time polymerase chain reaction. Ann Rheum Dis 64(5):780-782
64. Scheurlen W, Ramasubbu K, Wachowski O, Hemauer A, Modrow S (2001) Chronic autoimmune thrombopenia/neutropenia in a boy with persistent parvovirus B19 infection. J Clin Virol 20(3):173-178
65. Yaegashi N, Shiraishi H, Takeshita T, Nakamura M, Yajima A, Sugamura K (1989) Propagation of human parvovirus B19 in primary culture of erythroid lineage cells derived from fetal liver. J Virol 63(6):2422-2426
66. Ozawa K, Ayub J, Kajigaya S, Shimada T, Young N (1988) The gene encoding the nonstructural protein of B19 (human) parvovirus may be lethal in transfected cells. J Virol 62(8):2884-2889
67. Caillet-Fauquet P, Giambattista MD, Draps ML, Sandras F, Branckaert T, Launoit YD, Laub R (2004) Continuous-flow UVC irradiation: a new, effective, protein activity-preserving system for inactivating bacteria and viruses, including erythrovirus B19. J Virol Methods 118(2):131-139
68. Moffatt S, Yaegashi N, Tada K, Tanaka N, Sugamura K (1998) Human parvovirus B19 nonstructural (NS1) protein induces apoptosis in erythroid lineage cells. J Virol 72(4):3018-3028
69. Chen AY, Zhang EY, Guan W, Cheng F, Kleiboeker S, Yankee TM, Qiu J (2010) The small 11 kDa nonstructural protein of human parvovirus B19 plays a key role in inducing apoptosis during B19 virus infection of primary erythroid progenitor cells. Blood 115(5):1070-1080
70. Morita E, Tada K, Chisaka H, Asao H, Sato H, Yaegashi N, Sugamura K (2001) Human parvovirus B19 induces cell cycle arrest at G2 phase with accumulation of mitotic cyclins. J Virol 75(16):7555-7563
71. Luo Y, Kleiboeker S, Deng X, Qiu J (2013) Human parvovirus B19 infection causes cell cycle arrest of human erythroid progenitors at late S phase that favors viral DNA replication. J Virol 87(23):12766-12775
72. Morita E, Nakashima A, Asao H, Sato H, Sugamura K (2003) Human parvovirus B19 nonstructural protein (NS1) induces cell cycle arrest at G1 phase. J Virol 77(5):2915-2921
73. Luo Y, Lou S, Deng X, Liu Z, Li Y, Kleiboeker S, Qiu J (2011) Parvovirus B19 infection of human primary erythroid progenitor cells triggers ATR-Chk1 signaling, which promotes B19 virus replication. J Virol 85(16):8046-8055
74. Lou S, Luo Y, Cheng F, Huang Q, Shen W, Kleiboeker S, Tisdale JF, Liu Z, Qiu J (2012) Human parvovirus B19 DNA replication induces a DNA damage response that is dispensable for cell cycle arrest at phase G2/M. J Virol 86(19):10748-10758
75. Wan Z, Zhi N, Wong S, Keyvanfar K, Liu D, Raghavachari N, Munson PJ, Su S, Malide D, Kajigaya S, Young NS (2010) Human parvovirus B19 causes cell cycle arrest of human erythroid progenitors via deregulation of the E2F family of transcription factors. J Clin Investi 120(10):3530-3544
76. Adeyemi RO, Landry S, Davis ME, Weitzman MD, Pintel DJ (2010) Parvovirus minute virus of mice induces a DNA damage response that facilitates viral replication. PLoS Pathog 6(10):e1001141
77. Sol N, Le Junter J, Vassias I, Freyssinier JM, Thomas A, Prigent AF, Rudkin BB, Fichelson S, Morinet F (1999) Possible interactions between the NS-1 protein and tumor necrosis factor alpha pathways in erythroid cell apoptosis induced by human parvovirus B19. J Virol 73(10):8762-8770
78. Nakashima A, Morita E, Saito S, Sugamura K (2004) Human Parvovirus B19 nonstructural protein transactivates the p21/WAF1 through Sp1. Virology 329(2):493-504
79. Kivovich V, Gilbert L, Vuento M, Naides SJ (2012) The putative metal coordination motif in the endonuclease domain of human parvovirus B19 NS1 is critical for NS1 induced S phase arrest and DNA damage. Inter J Biol Sci 8(1):79
80. Poole BD, Kivovich V, Gilbert L, Naides SJ (2011) Parvovirus B19 nonstructural protein-induced damage of cellular DNA and resultant apoptosis. Int J Biol Sci 8(2):88
81. Hsu TC, Wu WJ, Chen MC, Tsay GJ (2004) Human parvovirus B19 non-structural protein (NS1) induces apoptosis through mitochondria cell death pathway in COS-7 cells. Scand J Infect Dis 36(8):570-577
82. Scaffidi C, Fulda S, Srinivasan A, Friesen C, Li F, Tomaselli KJ, Debatin KM, Krammer PH, Peter ME (1998) Two CD95 (APO-1/Fas) signaling pathways. EMBO J 17(6):1675-1687
83. Sprick MR, Walczak H (2004) The interplay between the Bcl-2 family and death receptor-mediated apoptosis. BBA Mol Cell Res 1644(2):125-132
84. Thammasri K, Rauhamäki S, Wang L, Filippou A, Kivovich V, Marjomäki V, Naides RJ, Gilbert L (2013) Human parvovirus B19 induced apoptotic bodies contain altered self-antigens that are phagocytosed by antigen presenting cells. PLoS ONE 8(6):e67179
85. Poole BD, Karetnyi YV, Naides SJ (2004) Parvovirus B19-induced apoptosis of hepatocytes. J Virol 78(14):7775-7783
86. Poole BD, Zhou J, Grote A, Schiffenbauer A, Naides SJ (2006) Apoptosis of liver-derived cells induced by parvovirus B19 nonstructural protein. J Virol 80(8):4114-4121
87. Nykky J, Tuusa JE, Kirjavainen S, Vuento M, Gilbert L (2010) Mechanisms of cell death in canine parvovirus-infected cells provide intuitive insights to developing nanotools for medicine. Int J Nanomed 5:417
88. Saxena L, Kumar GR, Saxena S, Chaturvedi U, Sahoo AP, Singh LV, Santra L, Palia SK, Desai GS, Tiwari AK (2013) Apoptosis induced by NS1 gene of canine parvovirus-2 is caspase dependent and p53 independent. Virus Res 173(2):426-430
89. Pan H, Zhong F, Pan S, Li X, Zhang F, Zhang K, Chen H (2012) Non-structural protein NS1 of canine parvovirus induces the apoptosis of cells. Wei sheng wu xue bao 52(3):367-373
90. Santra L, Rajmani RS, Ravi Kumar GVPPS, Saxena S, Dhara SK, Kumar A, Sahoo AP, Singh LV, Desai GS, Chaturvedi U, Kumar S, Tiwari AK (2014) Non-structural protein 1 (NS1) gene of canine parvovirus-2 regresses chemically induced skin tumors in Wistar rats. Res Vet Sci. doi: 10.1016/j.rvsc.2014.07.024
91. Noteborn MH, Koch G (1995) Chicken anaemia virus infection: molecular basis of pathogenicity. Avian Pathol 24(1):11-31
92. Adair BM (2000) Immunopathogenesis of chicken anemia virus infection. Dev Comp Immunol 24(2):247-255
93. Hoerr FJ (2010) Clinical aspects of immunosuppression in poultry. Avian Dis 54(1):2-15
94. Jeurissen SH, Wagenaar F, Pol JM, Van der Eb AJ, Noteborn MH (1992) Chicken anemia virus causes apoptosis of thymocytes after in vivo infection and of cell lines after in vitro infection. J Virol 66(12):7383-7388
95. Noteborn MH, De Boer GF, Van Roozelaar DJ, Karreman C, Kranenburg O, Vos JG, Jeurissen SH, Hoeben RC, Zantema A, Koch G (1991) Characterization of cloned chicken anemia virus DNA that contains all elements for the infectious replication cycle. J Virol 65(6):3131-3139
96. Danen-Van Oorschot AAAM, Fischer DF, Grimbergen JE, Klein B, Zhuang SM, Falkenburg JHF, Backendorf C, Quax PHA, Vandereb AJ, Noteborn MHM (1997) Apoptin induces apoptosis in human transformed and malignant cells but not in normal cells. Proc Natl Acad Sci 94(11):5843-5847
97. Noteborn MH, Danen-van Oorschot AA, van der Eb AJ (1998) Chicken anemia virus: induction of apoptosis by a single protein of a single-stranded DNA virus. In: Seminars in virology, vol 8, no 6. Academic Press, pp 497-504
98. Oro C, Jans DA (2004) The tumour specific pro-apoptotic factor apoptin (Vp3) from chicken anaemia virus. Curr Drug Targets 5(2):179-190
99. Tavassoli M, Guelen L, Luxon BA, Gaken J (2005) Apoptin: specific killer of tumor cells? Apoptosis 10:717-724
100. Danen-van Oorschot AA, Zhang YH, Leliveld SR, Rohn JL, Seelen MC, Bolk MW, Zon AV, Erkeland SJ, Abrahams JP, Mumberg D, Noteborn MHM (2003) Importance of nuclear localization of apoptin for tumor-specific induction of apoptosis. J Biol Chem 278(30):27729-27736
101. Heilman DW, Teodoro JG, Green MR (2006) Apoptin nucleocytoplasmic shuttling is required for cell type-specific localization, apoptosis, and recruitment of the anaphase-promoting complex/cyclosome to PML bodies. J Virol 80(15):7535-7545
102. Poon IK, Oro C, Dias MM, Zhang J, Jans DA (2005) Apoptin nuclear accumulation is modulated by a CRM1-recognized nuclear export signal that is active in normal but not in tumor cells. Cancer Res 65(16):7059-7064
103. Zhang YH, Leliveld SR, Kooistra K, Molenaar C, Rohn JL, Tanke HJ, Abrahams JP, Noteborn MHM (2003) Recombinant apoptin multimers kill tumor cells but are nontoxic and epitope-shielded in a normal-cell-specific fashion. Exp Cell Res 289(1):36-46
104. Rohn JL, Zhang YH, Aalbers RI, Otto N, Den Hertog J, Henriquez NV, Van De Velde CJ, Kuppen PJ, Mumberg D, Donner P, Noteborn MHM (2002) A tumor-specific kinase activity regulates the viral death protein apoptin. J Biol Chem 277(52):50820-50827
105. Wang QM, Fan GC, Chen JZ, Chen HP, He FC (2004) A putative NES mediates cytoplasmic localization of apoptin in normal cells. Acta Biochem Biophys Sin 36(12):817-823
106. Huo DH, Yi LN, Yang J (2008) Interaction with Ppil3 leads to the cytoplasmic localization of apoptin in tumor cells. Biochem Biophys Res Commun 372(1):14-18
107. Guelen L, Paterson H, Gäken J, Meyers M, Farzaneh F, Tavassoli M (2004) TAT-apoptin is efficiently delivered and induces apoptosis in cancer cells. Oncogene 23:1153-1165
108. Rohn JL, Zhang YH, Leliveld SR, Danen-van Oorschot AAAM, Henriquez NV, Abrahams JP, Noteborn MHM (2005) Relevance of apoptin's integrity for its functional behavior. J Virol 79(2):1337-1338
109. Lee YH, Cheng CM, Chang YF, Wang TY, Yuo CY (2007) Apoptin T108 phosphorylation is not required for its tumor-specific nuclear localization but partially affects its apoptotic activity. Biochem Biophys Res Commun 354:391-395
110. Janssen K, Hofmann TG, Jans DA, Hay RT, Schulze-Osthoff K, Fischer U (2006) Apoptin is modified by SUMO conjugation and targeted to promyelocytic leukemia protein nuclear bodies. Oncogene 26(11):1557-1566
111. Lanz HL, Florea BI, Noteborn MH, Backendorf C (2012) Development and application of an in vitro apoptin kinase assay. Anal Biochem 421(1):68-74
112. Leliveld SR, Dame RT, Rohn JL, Noteborn MHM, Abrahams JP (2004) Apoptin's functional N-and C-termini independently bind DNA. FEBS Lett 557(1):155-158
113. Maddika S, Bay GH, Kroczak TJ, Ande SR, Wiechec E, Gibson SB, Los M (2007) Akt is transferred to the nucleus of cells treated with apoptin, and it participates in apoptin-induced cell death. Cell Prolif 40(6):835-848
114. Maddika S, Panigrahi S, Wiechec E, Wesselborg S, Fischer U, Schulze-Osthoff K, Los M (2009) Unscheduled Akt-triggered activation of cyclin-dependent kinase 2 as a key effector mechanism of apoptin's anticancer toxicity. Mol Cell Biol 29(5):1235-1248
115. Maddika S, Wiechec E, Ande SR, Poon IK, Fischer U, Wesselborg S, Jan DA, Schulze-Osthoff K, Los M (2007) Interaction with PI3-kinase contributes to the cytotoxic activity of apoptin. Oncogene 27(21):3060-3065
116. Chen K, Luo Z, Tang J, Zheng SJ (2011) A critical role of heat shock cognate protein 70 in Apoptin-induced phosphorylation of Akt. Biochem Biophys Res Commun 409(2):200-204
117. Bullenkamp J, Tavassoli M (2014) Signalling of apoptin. In: Anticancer genes. Springer, London, pp 11-37
118. Los M, Maddika S, Erb B, Schulze-Osthoff K (2009) Switching Akt: from survival signaling to deadly response. BioEssays 31(5):492-495
119. Maddika S, Ande SR, Wiechec E, Hansen LL, Wesselborg S, Los M (2008) Akt-mediated phosphorylation of CDK2 regulates its dual role in cell cycle progression and apoptosis. J Cell Sci 121(7):979-988
120. Kucharski TJ, Gamache I, Gjoerup O, Teodoro JG (2011) DNA damage response signaling triggers nuclear localization of the chicken anemia virus protein apoptin. J Virol 85(23):12638-12649
121. Jiang J, Cole D, Westwood N, Macpherson L, Farzaneh F, Mufti G, Tavassoli M, Gäken J (2010) Crucial roles for protein kinase C isoforms in tumor-specific killing by apoptin. Cancer Res 70(18):7242-7252
122. Martelli AM, Faenza I, Billi AM, Fala F, Cocco L, Manzoli L (2003) Nuclear protein kinase C isoforms: key players in multiple cell functions? Histol Histopathol 18:1301-1312
123. Redig AJ, Platanias LC (2007) The protein kinase C (PKC) family of proteins in cytokine signaling in hematopoiesis. J Interferon Cytokine Res 27:623-636
124. Zimmerman R, Peng DJ, Lanz H, Zhang YH, Danen-van Oorschot A, Qu S, Backendorf C, Noteborn M (2012) PP2A inactivation is a crucial step in triggering apoptin-induced tumor-selective cell killing. Cell Death Dis 3(4):e291
125. Zhuang SM, Landegent JE, Verschueren CA, Falkenburg JH, Van Ormondt H, Van der Eb AJ, Noteborn MH (1995) Apoptin, a protein encoded by chicken anemia virus, induces cell death in various human hematologic malignant cells in vitro. Leukemia 9:S118-S120
126. Danen-van Oorschot AAAM, van Der Eb AJ, Noteborn MHM (2000) The chicken anemia virus-derived protein apoptin requires activation of caspases for induction of apoptosis in human tumor cells. J Virol 74(15):7072-7078
127. Maddika S, Booy EP, Johar D, Gibson SB, Ghavami S, Los M (2005) Cancer-specific toxicity of apoptin is independent of death receptors but involves the loss of mitochondrial membrane potential and the release of mitochondrial cell-death mediators by a Nur77-dependent pathway. J Cell Sci 118(19):4485-4493
128. Burek M, Maddika S, Burek CJ, Daniel PT, Schulze-Osthoff K, Los M (2005) Apoptin-induced cell death is modulated by Bcl-2 family members and is Apaf-1 dependent. Oncogene 25(15):2213-2222
129. Erster S, Moll UM (2004) Stress-induced p53 runs a direct mitochondrial death program: its role in physiologic and pathophysiologic stress responses in vivo. Cell Cycle 3:86-89
130. Jeong JH, Park JS, Moon B, Kim MC, Kim JK, Lee S, Suh H, Kim ND, Kim JM, Park YC, Yoo YH (2003) Orphan nuclear receptor Nur77 translocates to mitochondria in the early phase of apoptosis induced by synthetic chenodeoxycholic acid derivatives in human stomach cancer cell line SNU-1. Ann N Y Acad Sci 1010:171-177
131. Lin B, Kolluri SK, Lin F, Liu W, Han YH, Cao X, Dawson MI, Reed JC, Zhang XK (2004) Conversion of Bcl-2 from protector to killer by interaction with nuclear orphan receptor Nur77/TR3. Cell 116(4):527-540
132. Kolluri SK, Zhu X, Zhou X, Lin B, Chen Y, Sun K, Tian X, Town J, Cao X, Lin F, Zhai D, Kitada S, Luciano F, O'donnell E, Cao F, He F, Lin J, Reed JC, Satterthwait AC, Zhang XK (2008) A short Nur77-derived peptide converts Bcl-2 from a protector to a killer. Cancer Cell 14(4):285-298
133. Li Q, Zhang H, Tan C, Peng W, Ren G, Jia B, He Y, Wang P, Zhou X, Xiang T (2013) AdHu5-apoptin induces G2/M arrest and apoptosis in p53-mutated human gastric cancer SGC-7901 cells. Tum Biol 34(6):3569-3577
134. Danen-Van Oorschot AA, van der Eb AJ, Noteborn MH (1999) BCL-2 stimulates Apoptin®-induced apoptosis. In: Drug resistance in leukemia and lymphoma III. Springer US, pp 245-249
135. Schoop RA, Kooistra K, de Jong B, Robert J, Noteborn MH (2004) Bcl-xL inhibits p53-but not apoptin-induced apoptosis in head and neck squamous cell carcinoma cell line. Inter J Can 109(1):38-42
136. Teodoro JG, Heilman DW, Parker AE, Green MR (2004) The viral protein apoptin associates with the anaphase-promoting complex to induce G2/M arrest and apoptosis in the absence of p53. Genes Dev 18(16):1952-1957
137. Yuan L, Zhang L, Dong X, Zhao H, Li S, Han D, Liu X (2013) Apoptin selectively induces the apoptosis of tumor cells by suppressing the transcription of HSP70. Tumor Biol 34(1):577-585
138. Lanz HL, Zimmerman RME, Brouwer J, Noteborn MHM, Backendorf C (2013) Mitotic catastrophe triggered in human cancer cells by the viral protein apoptin. Cell Death Dis 4(2):e487
139. Cheng CM, Huang SP, Chang YF, Chung WY, Yuo CY (2003) The viral death protein Apoptin interacts with Hippi, the protein interactor of Huntingtin-interacting protein 1. Biochem Biophys Res Commun 305(2):359-364
140. Danen-van Oorschot AAAM, Voskamp P, Seelen MCMJ, Van Miltenburg MHAM, Bolk MW, Tait SW, Boesen-de Cock JGR, Rohn JL, Borst J, Noteborn MHM (2004) Human death effector domain-associated factor interacts with the viral apoptosis agonist apoptin and exerts tumor-preferential cell killing. Cell Death Differ 11(5):564-573
141. Janssen K, Hofmann TG, Jans DA, Hay RT, Schulze-Osthoff, Fischer U (2007) Apoptin is modified by SUMO conjugation and targeted to promyelocytic leukemia protein nuclear bodies. Oncogene 26:1557-1566
142. Sun GJ, Tong X, Dong Y, Mei ZZ, Sun ZX (2002) Identification of a protein interacting with apoptin from human leucocyte cDNA library by using yeast two-hybrid screening. Sheng wu hua xue yu sheng wu wu li xue bao 34(3):369-372
143. Müller U, Roberts MP, Engel DA, Doerfler W, Shenk T (1989) Induction of transcription factor AP-1 by adenovirus E1A protein and cAMP. Genes Dev 3(12a):1991-2002
144. Kleinberger T, Shenk T (1993) Adenovirus E4orf4 protein binds to protein phosphatase 2A, and the complex down regulates E1A-enhanced junB transcription. J Virol 67:7556-7560
145. Bondesson M, Ohman K, Mannervik M, Fan S, Akusjarvi G (1996) Adenovirus E4 open reading 4 protein autoregulates E4 transcription by inhibiting E1A transactivation of the E4 promoter. J Virol 70:3844-3851
146. Estmer Nilsson C, Petersen-Mahrt S, Durot C, Shtrichman R, Krainer AR, Kleinberger T, Akusjarvi G (2001) The adenovirus E4-ORF4 splicing enhancer protein interacts with a subset of phosphorylated SR proteins. EMBO J 20:864-871
147. Marcellus RC, Lavoie JN, Boivin D, Shore GC, Ketner G, Branton PE (1998) The early region 4 orf4 protein of human adenovirus type 5 induces p53-independent cell death by apoptosis. J Virol 72:7144-7153
148. Lavoie JN, Nguyen M, Marcellus RC, Branton PE, Shore GC (1998) E4orf4, a novel adenovirus death factor that induces p53-independent apoptosis by a pathway that is not inhibited by zVAD-fmk. J Cell Biol 140:637-645
149. Shtrichman R, Kleinberger T (1998) Adenovirus type 5 E4 open reading frame 4 protein induces apoptosis in transformed cells. J Virol 72:2975-2982
150. Robert A, Miron MJ, Champagne C, Gingras MC, Branton PE, Lavoie JN (2002) Distinct cell death pathways triggered by the adenovirus early region 4 ORF 4 protein. J Cell Biol 158(3):519-528
151. Livne A, Shtrichman R, Kleinberger T (2001) Caspase activation by adenovirus E4orf4 protein is cell line-specific and is mediated by the death receptor pathway. J Virol 75:789-798
152. Lavoie JN, Champagne C, Gingras M-C, Robert A (2000) Adenovirus E4 open reading frame 4-induced apoptosis involves dysregulation of Src family kinases. J Cell Biol 150:1037-1055
153. Shtrichman R, Sharf R, Barr H, Dobner T, Kleinberger T (1999) Induction of apoptosis by adenovirus E4orf4 protein is specific to transformed cells and requires an interaction with protein phosphatase 2A. Proc Natl Acad Sci USA 96:10080-10085
154. Champagne C, Landry MC, Gingras MC, Lavoie JN (2004) Activation of adenovirus type 2 early region 4 ORF4 cytoplasmic death function by direct binding to Src kinase domain. J Biol Chem 279(24):25905-25915
155. Gingras MC, Champagne C, Roy M, Lavoie JN (2002) Cytoplasmic death signal triggered by SRC-mediated phosphorylation of the adenovirus E4orf4 protein. Mol Cell Biol 22:41-56
156. Mui MZ, Kucharski M, Miron MJ, Hur WS, Berghuis AM, Blanchette P, Branton PE (2013) Identification of the adenovirus E4orf4 protein binding site on the B55α and Cdc55 regulatory subunits of PP2A: implications for PP2A function, tumor cell killing and viral replication. PLoS Pathog 9(11):e1003742
157. Kornitzer D, Sharf R, Kleinberger T (2001) Adenovirus E4orf4 protein induces PP2A-dependent growth arrest in S. cerevisiae and interacts with the anaphase promoting com-plex/cyclosome. J Cell Biol 154:331-344
158. Roopchand DE, Lee JM, Shahinian S, Paquette D, Bussey H, Branton PE (2001) Toxicity of human adenovirus E4orf4 protein in Saccharomyces cerevisiae results from interactions with the Cdc55 regulatory B subunit of PP2A. Oncogene 20:5279-5290
159. Ossareh-Nazari B, Bachelerie F, Dargemont C (1997) Evidence for a role of CRM1 in signal-mediated nuclear protein export. Science 278(5335):141-144
160. Branton PE, Roopchand DE (2001) The role of adenovirus E4orf4 protein in viral replication and cell killing. Oncogene 20(54):7855-7865
161. Miron MJ, Gallouzi IE, Lavoie JN, Branton PE (2004) Nuclear localization of the adenovirus E4orf4 protein is mediated through an arginine-rich motif and correlates with cell death. Oncogene 23(45):7458-7468
162. Brestovitsky A, Sharf R, Mittelman K, Kleinberger T (2011) The adenovirus E4orf4 protein targets PP2A to the ACF chromatin-remodeling factor and induces cell death through regulation of SNF2h-containing complexes. Nucleic Acids Res, gkr231
163. Li S, Szymborski A, Miron MJ, Marcellus R, Binda O, Lavoie JN, Branton PE (2008) The adenovirus E4orf4 protein induces growth arrest and mitotic catastrophe in H1299 human lung carcinoma cells. Oncogene 28:390-400
164. Li S, Brignole C, Marcellus R, Thirlwell S, Binda O, McQuoid MJ, Branton PE (2009) The adenovirus E4orf4 protein induces G2/M arrest and cell death by blocking protein phosphatase 2A activity regulated by the B55 subunit. J Virol 83(17):8340-8352
165. Cabon L, Sriskandarajah N, Mui MZ, Teodoro JG, Blanchette P, Branton PE (2013) Adenovirus E4orf4 protein-induced death of p53-/-H1299 human cancer cells follows a G1 arrest of both tetraploid and diploid cells due to a failure to initiate DNA synthesis. J Virol 87(24):13168-13178
166. Avital-Shacham M, Sharf R, Kleinberger T (2014) NTPDASE4 gene products cooperate with the adenovirus E4orf4 protein through PP2A-dependent and-independent mechanisms and contribute to induction of cell death. J Virol 88(11):6318-6328
167. Bocchia M, Bronte V, Colombo MP, De Vincentiis A, Di Nicola M, Forni G, Lanata L, Lemoli RM, Massaia M, Rondelli D, Zanon P, Tura S (2000) Antitumor vaccination: where we stand. Haematologica 85(11):1172-1206
168. Rosenberg SA, Yang JC, Restifo NP (2004) Cancer immunotherapy: moving beyond current vaccines. Nat Med 10(9):909-915
169. Heath WR, Carbone FR (2001) Cross-presentation, dendritic cells, tolerance and immunity. Annu Rev Immunol 19(1):47-64
170. Moehler MH, Zeidler M, Wilsberg V, Cornelis JJ, Woelfel T, Rommelaere J, Galle PR, Heike M (2005) Parvovirus H-1-induced tumor cell death enhances human immune response in vitro via increased phagocytosis, maturation, and cross-presentation by dendritic cells. Hum Gene Ther 16(8):996-1005
171. Blachère NE, Darnell RB, Albert ML (2005) Apoptotic cells deliver processed antigen to dendritic cells for cross-presentation. PLoS Biol 3(6):e185
172. Guermonprez P, Valladeau J, Zitvogel L, Théry C, Amigorena S (2002) Antigen presentation and T cell stimulation by dendritic cells. Annu Rev Immunol 20(1):621-667
173. Albert ML, Sauter B, Bhardwaj N (1998) Dendritic cells acquire antigen from apoptotic cells and induce class I-restricted CTLs. Nature 392(6671):86-89
174. Albert ML, Pearce SFA, Francisco LM, Sauter B, Roy P, Silverstein RL, Bhardwaj N (1998) Immature dendritic cells phagocytose apoptotic cells via αvβ5 and CD36, and cross-present antigens to cytotoxic T lymphocytes. J Exp Med 188(7):1359-1368
175. Chen Z, Moyana T, Saxena A, Warrington R, Jia Z, Xiang J (2001) Efficient antitumor immunity derived from maturation of dendritic cells that had phagocytosed apoptotic/necrotic tumor cells. Int J Cancer 93(4):539-548
176. Festjens N, Vanden Berghe T, Vandenabeele P (2006) Necrosis, a well-orchestrated form of cell demise: signalling cascades, important mediators and concomitant immune response. BBA Bioenergetics 1757(9):1371-1387
177. Binder RJ, Kelly JB, Vatner RE, Srivastava PK (2007) Specific immunogenicity of heat shock protein gp96 derives from chaperoned antigenic peptides and not from contaminating proteins. J Immunol 179(11):7254-7261
178. Giodini A, Cresswell P (2008) Hsp90-mediated cytosolic refolding of exogenous proteins internalized by dendritic cells. EMBO J 27(1):201-211
179. Pietersen AM, Van der Eb MM, Rademaker HJ, Van den Wollenberg DJM, Rabelink MJWE, Kuppen PJK, & Noteborn. MH (1999) Specific tumor-cell killing with adenovirus vectors containing the apoptin gene. Gene Ther 6(5):882-892
180. Zhang M, Wang J, Li C, Hu N, Wang K, Ji H, He D, Quan C, Li X, Li Y (2013) Potent growth-inhibitory effect of a dual cancer-specific oncolytic adenovirus expressing apoptin on prostate carcinoma. Inter J Oncolo 42(3):1052-1060
181. Xiao L, Yan L, Zhongmei W, Chang L, Huijun L, Mingyao T, Kuoshi J, Sun L, Pegn G, Yan E, Xiaohong X, Shifu K, Zhuoyue W, Yuhang W, Ningyi J (2010) Potent anti-tumor effects of a dual specific oncolytic adenovirus expressing apoptin in vitro and in vivo. Mol Can 9(1):1-12
182. Qi Y, Guo H, Hu N, He D, Zhang S, Chu Y, Huang Y, Li X, Jin N (2014) Preclinical pharmacology and toxicology study of Ad-hTERT-E1a-Apoptin, a novel dual cancer-specific oncolytic adenovirus. Toxicol Appl Pharmacol. doi: 10.1016/j.taap.2014.08.008
183. Liu L, Wu W, Zhu G, Liu L, Guan G, Li X, Jin N, Chi B (2012) Therapeutic efficacy of an hTERT promoter-driven oncolytic adenovirus that expresses apoptin in gastric carcinoma. Int J Mol Med 30(4):747
184. Wang C, Wang W, Wang J, Zhan H, Jiang L, Yan R, Hou Z, Zhu H, Yu L, Shi Y, Ding M, Ke C (2013) Apoptin induces apoptosis in nude mice allograft model of human bladder cancer by altering multiple bladder tumor-associated gene expression profiles. Tum Biol 34(3):1667-1678
185. van der Eb MM, Pietersen AM, Speetjens FM, Kuppen PJ, van de Velde CJ, Noteborn MH, Hoeben RC (2002) Gene therapy with apoptin induces regression of xenografted human hepatomas. Cancer Gene Ther 9(1):53-61
186. Liu X, Elojeimy S, El-Zawahry AM, Holman DH, Bielawska A, Bielawski J, Rubinchik S, Guo GW, Dong JY, Keane T, Hannun YA, Tavassoli M, Norris JS (2006) Modulation of ceramide metabolism enhances viral protein apoptin's cytotoxicity in prostate cancer. Mol Ther 14(5):637-646
187. Schoop RA, de Jong RJB, Noteborn MH (2008) Apoptin induces apoptosis in an oral cancer mouse model. Cancer Biol Ther 7(9):1368-1373
188. Harvey BG, Hackett NR, El-Sawy T, Rosengart TK, Hirschowitz EA, Lieberman MD, Lesser ML, Crystal RG (1999) Variability of human systemic humoral immune responses to adenovirus gene transfer vectors administered to different organs. J Virol 73(8):6729-6742
189. Ye F, Zhong B, Dan G, Jiang F, Sai Y, Zhao J, Sun H, Zou Z (2013) Therapeutic anti-tumor effect of exogenous apoptin driven by human survivin gene promoter in a lentiviral construct. Arch Med Sci 9(3):561-568
190. Han SX, Zhao J, Ma JL, Huang C, Lü Y, Ou W, Jia X (2010) The effect of the fused gene of SP-TAT-Apoptin transfected by lentivirus on HepG2 cells. Xi bao yu fen zi mian yi xue za zhi 26(4):310-312
191. Han SX, Ma JL, Lv Y, Huang C, Liang HH, Duan KM (2008) Secretory Transactivating Transcription-apoptin fusion protein induces apoptosis in hepatocellular carcinoma HepG2 cells. World J Gastroenterol 14(23):3642
192. Ma JL, Han SX, Zhao J, Zhang D, Wang L, Li YD, Zhu Q (2012) Systemic delivery of lentivirus-mediated secretable TAT-apoptin eradicates hepatocellular carcinoma xenografts in nude mice. Int J Oncol 41(3):1013-1020
193. Pan Y, Fang L, Fan H, Luo R, Zhao Q, Chen H, Xiao S (2010) Antitumor effects of a recombinant pseudotype baculovirus expressing apoptin in vitro and in vivo. Int J Can 126(11):2741-2751
194. Strauss R, Hüser A, Ni S, Tuve S, Kiviat N, Sow PS, Hofmann C, Lieber A (2007) Baculovirus-based vaccination vectors allow for efficient induction of immune responses against Plasmodium falciparum circumsporozoite protein. Mol Ther 15(1):193-202
195. Olijslagers S, Dege AY, Dinsart C, Voorhoeve M, Rommelaere J, Noteborn MH, Cornelis JJ (2001) Potentiation of a recombinant oncolytic parvovirus by expression of apoptin. Cancer Gene Ther 8(12):958-965
196. Li X, Jin N, Mi Z, Lian H, Sun L, Li X, Zheng H (2006) Antitumor effects of a recombinant fowlpox virus expressing apoptin in vivo and in vitro. Int J Cancer 119(12):2948-2957
197. Wu Y, Zhang X, Wang X, Wang L, Hu S, Liu X, Meng S (2011) Apoptin enhances the oncolytic properties of Newcastle disease virus. Intervirology 55(4):276-286
198. Kochneva GV, Babkina IN, Lupan TA, Grazhdantseva AA, Yudin PV, Sivolobova GF, Shvalov AN, Popov EG, Babkin IV, Netesov SV, Chumakov PM (2013) Apoptin enhances the oncolytic activity of vaccinia virus in vitro. Mol Biol 47(5):733-742
199. Shoae-Hassani A, Keyhanvar P, Seifalian AM, Mortazavi-Tabatabaei SA, Ghaderi N, Issazadeh K, Amirmozafari N, Verdi J (2013) λ Phage nanobioparticle expressing apoptin efficiently suppress human breast carcinoma tumor growth in vivo. PLoS ONE 8(11):e79907
200. Cao HD, Yang YX, Lü L, Liu SN, Wang PL, Tao XH, Wang LJ, Xiang TX (2010) Attenuated Salmonella typhimurium carrying TRAIL and VP3 genes inhibits the growth of gastric cancer cells in vitro and in vivo. Tumori 96(2):296
201. Guan GF, Zhao M, Liu LM, Jin CS, Sun K, Zhang DJ, Yu DJ, Cao HW, Lu YQ, Wen LJ (2013) Salmonella typhimurium mediated delivery of apoptin in human laryngeal cancer. Int J Med Sci 10(12):1639
202. Natesan S, Kataria JM, Dhama K, Bhardwaj N, Sylvester A (2006) Anti-neoplastic effect of chicken anemia virus VP3 protein (apoptin) in Rous sarcoma virus-induced tumours in chicken. J Gen Virol 87(10):2933-2940
203. Mitrus I, Missol-Kolka EWA, Plucienniczak A, Szala S (2005) Tumour therapy with genes encoding apoptin and E4orf4. Anticancer Res 25(2A):1087-1090
204. Lian H, Jin N, Li X, Mi Z, Zhang J, Sun L, Li X, Zheng H, Li P (2007) Induction of an effective anti-tumor immune response and tumor regression by combined administration of IL-18 and apoptin. Cancer Immunol Immunother 56(2):181-192
205. An S, Nam K, Choi S, Bai CZ, Lee Y, Park JS (2013) Nonviral gene therapy in vivo with PAM-RG4/apoptin as a potential brain tumor therapeutic. Int J Nanomed 8:821
206. Pennant WA, An S, Gwak SJ, Choi S, Banh DT, Nguyen AB, Song HY, Ha Y, Park JS (2013) Local non-viral gene delivery of apoptin delays the onset of paresis in an experimental model of intramedullary spinal cord tumor. Spinal Cord 52:3-8
207. Sun J, Yan Y, Wang XT, Liu XW, Peng DJ, Wang M, Tian J, Zong YQ, Zhang YH, Noteborn MHM, Qu S (2009) PTD4-apoptin protein therapy inhibits tumor growth in vivo. Inter J Can 124(12):2973-2981
208. Jin JL, Gong J, Yin TJ, Lu YJ, Xia JJ, Xie YY, Di Y, He L, Guo JL, Sun J, Noteborn MHM, Qu S (2011) PTD4-apoptin protein and dacarbazine show a synergistic antitumor effect on B16-F1 melanoma in vitro and in vivo. Eur J Pharmacol 654(1):17-25
209. Wang DM, Zhou Y, Xie HJ, Ma XL, Wang X, Chen H, Huang BR (2006) Cytotoxicity of a recombinant fusion protein of adenovirus early region 4 open reading frame 4 (E4orf4) and human epidermal growth factor on p53-deficient tumor cells. Anticancer Drugs 17(5):527-537
210. Zhou Y, Chen H, Ma XL, Xie HJ, Wang CL, Zhang SH, Wang X, Huang BR (2009) Fusion protein of adenovirus E4orf4 and human epidermal growth factor inhibits tumor cell growth. Int J Cancer 125(5):1186-1192
211. Galioot A, Godet AN, Maire V, Falanga PB, Cayla X, Baron B, England P (1830) Garcia A (2013) Transducing properties of a pre-structured α-helical DPT-peptide containing a short canine adenovirus type 2 E4orf4 PP2A1-binding sequence. BBA Gen Subjects 6:3578-3583
212. Wolkersdörfer GW, Morris JC, Ehninger G, Ramsey WJ (2004) Trans-complementing adenoviral vectors for oncolytic therapy of malignant melanoma. J Gene Med 6(6):652-662